Innovating Works

FONDAZIONE POLIAMBULANZA

Desconocido
SECRET: Exploring the therapeutic potential of perinatal cell SECRETomes Over the past two decades, cells isolated from human perinatal (or birth-associated) tissues (amniotic membrane, umbilical cord tissue and c...
2024-07-16 - 2028-08-31 | Financiado
LIFESAVER: Living Impact on Fetal Evolution Shelter Analyze Validate Empower Regulations FONDAZIONE POLIAMBULANZA participó en un H2020: H2020-LC-GD-2020 In Europe about 75% of all neonatal deaths and 60% of all infant deaths occur in infants born preterm, and worldwide 450 neonatal deaths occ...
2021-09-28 - 2025-10-31 | Financiado
HIPGEN: Placenta expanded adherent stromal cells PLX PAD as an innovative therapy for improving recovery a... FONDAZIONE POLIAMBULANZA participó en un H2020: H2020-SC1-2016-2017 Aim of the HIPGEN project is to develop the first cell therapy to improve functional recovery following hip fracture arthroplasty. Hip fract...
2017-11-21 - 2022-09-30 | Financiado
DR-BOB: Demand Response in Block of Buildings FONDAZIONE POLIAMBULANZA participó en un H2020: H2020-EE-2014-2015 The aim of the DR-BOB project is to demonstrate the economic and environmental benefits of demand response in blocks of buildings for the di...
2016-02-04 - 2019-08-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.